April 2011
5 posts
Drug company R&D: Nowhere near $1 billion. - By... →
// Cost of brining a novel drug to market is $55 million, new research shows
// Prior work insisted that the cost was about $1.32 Billion, no biggie, just a rounding error maybe
HopperMedicine, damn worth it!
Like many others I suffer from seasonal allergies, specifically in Spring. Unfortunately, I forgot to renew my Fluticasone nasal steroid spray prescription recently. So when the pollen came out to play this weekend I was not prepared… I thought about my options and realized, my regular Family Doc can’t call in prescriptions on the weekends. So I can either
See a minute clinic and pay...
Use of bisphosphonates and reduced risk of... →
// CONCLUSION The use of oral bisphosphonates for more than 1 year was associated with a 59% relative reduction in the risk of colorectal cancer, similar to the recently reported association of this drug class with reduction in breast cancer risk.
(via J. Clin Oncol April 2011)
Medical News: UV-A1 Eludes Most Anti-Aging Creams →
// Of note, the most expensive product tested ($64/ounce, No. 3 in sales) contained no UV-A1 protection, and the two biggest sellers had high levels of octocrylene, inadequate levels of avobenzone, and no zinc oxide.
“Unaware that the SPF value does not reflect the degree of UV-A protection, consumers using these products believe they are fully protected from the entire UV...
What Distinguishes Top-Performing Hospitals in... →
// High-performing hospitals were characterized by an organizational culture that supported efforts to improve AMI care across the hospital. Evidence-based protocols and processes, although important, may not be sufficient for achieving high hospital performance in care for patients with AMI.